Radosław Januchowski

2.2k total citations
53 papers, 1.8k citations indexed

About

Radosław Januchowski is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Radosław Januchowski has authored 53 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 25 papers in Oncology and 12 papers in Immunology. Recurrent topics in Radosław Januchowski's work include Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Radosław Januchowski is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Cancer therapeutics and mechanisms (8 papers) and Ovarian cancer diagnosis and treatment (7 papers). Radosław Januchowski collaborates with scholars based in Poland, Germany and France. Radosław Januchowski's co-authors include M. Zabel, Karolina Wojtowicz, Michał Nowicki, Małgorzata Andrzejewska, Karolina Sterzyńska, Piotr Zawierucha, Marcin Ruciński, Monika Świerczewska, Paweł P. Jagodzińśki and Andrzej Klejewski and has published in prestigious journals such as International Journal of Molecular Sciences, Molecules and Cancer Letters.

In The Last Decade

Radosław Januchowski

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radosław Januchowski Poland 24 1.1k 736 476 224 201 53 1.8k
Curt Balch United States 19 1.7k 1.6× 971 1.3× 759 1.6× 175 0.8× 202 1.0× 44 2.4k
Naoyo Nishida Japan 12 837 0.8× 401 0.5× 366 0.8× 150 0.7× 94 0.5× 27 1.5k
Lijun Di China 25 1.0k 1.0× 602 0.8× 389 0.8× 236 1.1× 64 0.3× 102 1.9k
Danhui Weng China 22 926 0.9× 492 0.7× 471 1.0× 160 0.7× 227 1.1× 41 1.5k
Noor A. Lokman Australia 20 869 0.8× 342 0.5× 357 0.8× 176 0.8× 99 0.5× 42 1.4k
Vijay Pandey China 30 1.4k 1.3× 658 0.9× 706 1.5× 281 1.3× 54 0.3× 105 2.5k
Douglas C. Marchion United States 23 1.8k 1.7× 609 0.8× 253 0.5× 156 0.7× 84 0.4× 66 2.3k
Imayavaramban Lakshmanan United States 27 1.5k 1.4× 961 1.3× 407 0.9× 504 2.3× 70 0.3× 43 2.2k
Yubin Mao China 18 1.1k 1.1× 687 0.9× 502 1.1× 220 1.0× 34 0.2× 23 2.0k
Luca Pasquini Italy 22 1.1k 1.0× 359 0.5× 577 1.2× 328 1.5× 79 0.4× 40 1.6k

Countries citing papers authored by Radosław Januchowski

Since Specialization
Citations

This map shows the geographic impact of Radosław Januchowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radosław Januchowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radosław Januchowski more than expected).

Fields of papers citing papers by Radosław Januchowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radosław Januchowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radosław Januchowski. The network helps show where Radosław Januchowski may publish in the future.

Co-authorship network of co-authors of Radosław Januchowski

This figure shows the co-authorship network connecting the top 25 collaborators of Radosław Januchowski. A scholar is included among the top collaborators of Radosław Januchowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radosław Januchowski. Radosław Januchowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Korbecki, Jan, et al.. (2025). The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models. International Journal of Molecular Sciences. 26(3). 1124–1124. 7 indexed citations
2.
Sterzyńska, Karolina, et al.. (2025). Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs. International Journal of Molecular Sciences. 26(12). 5800–5800. 1 indexed citations
3.
Świerczewska, Monika, et al.. (2025). Doxorubicin and topotecan resistance in ovarian cancer: Gene expression and microenvironment analysis in 2D and 3D models. Biomedicine & Pharmacotherapy. 183. 117804–117804. 2 indexed citations
4.
Świerczewska, Monika, Karolina Sterzyńska, Marcin Ruciński, et al.. (2023). The response and resistance to drugs in ovarian cancer cell lines in 2D monolayers and 3D spheroids. Biomedicine & Pharmacotherapy. 165. 115152–115152. 35 indexed citations
5.
Sterzyńska, Karolina, Monika Świerczewska, Karolina Wojtowicz, et al.. (2022). The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines. Biomedicine & Pharmacotherapy. 150. 113036–113036. 9 indexed citations
6.
Świerczewska, Monika, Karolina Sterzyńska, Karolina Wojtowicz, et al.. (2019). PTPRK Expression Is Downregulated in Drug Resistant Ovarian Cancer Cell Lines, and Especially in ALDH1A1 Positive CSCs-Like Populations. International Journal of Molecular Sciences. 20(8). 2053–2053. 17 indexed citations
7.
Sterzyńska, Karolina, Andrzej Klejewski, Monika Świerczewska, et al.. (2019). Expression of Osteoblast-Specific Factor 2 (OSF-2, Periostin) Is Associated with Drug Resistance in Ovarian Cancer Cell Lines. International Journal of Molecular Sciences. 20(16). 3927–3927. 19 indexed citations
8.
Świerczewska, Monika, Andrzej Klejewski, Karolina Wojtowicz, et al.. (2017). New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines. Molecules. 22(10). 1717–1717. 24 indexed citations
9.
Wojtowicz, Karolina, Radosław Januchowski, Michał Nowicki, & M. Zabel. (2017). vPARP Adjusts MVP Expression in Drug-resistant Cell Lines in Conjunction with MDR Proteins. Anticancer Research. 37(6). 3015–3023. 8 indexed citations
10.
Lang, Valérie, Fabienne Aillet, Wendy Xolalpa, et al.. (2017). Analysis of defective protein ubiquitylation associated to adriamycin resistant cells. Cell Cycle. 16(24). 2337–2344. 5 indexed citations
11.
Wojtowicz, Karolina, Radosław Januchowski, Michał Nowicki, & M. Zabel. (2015). Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines. Biomedicine & Pharmacotherapy. 74. 49–56. 36 indexed citations
12.
Januchowski, Radosław, Piotr Zawierucha, Marcin Ruciński, & M. Zabel. (2014). Microarray-based detection and expression analysis of extracellular matrix proteins in drug-resistant ovarian cancer cell lines. Oncology Reports. 32(5). 1981–1990. 59 indexed citations
13.
Januchowski, Radosław, Piotr Zawierucha, Marcin Ruciński, et al.. (2014). Drug transporter expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line. Biomedicine & Pharmacotherapy. 68(4). 447–453. 65 indexed citations
14.
Szaflarski, Witold, Patrycja Sujka‐Kordowska, Radosław Januchowski, et al.. (2013). Nuclear localization of P-glycoprotein is responsible for protection of the nucleus from doxorubicin in the resistant LoVo cell line. Biomedicine & Pharmacotherapy. 67(6). 497–502. 35 indexed citations
15.
Januchowski, Radosław, Karolina Wojtowicz, Patrycja Sujka‐Kordowska, Małgorzata Andrzejewska, & M. Zabel. (2012). MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines. BioMed Research International. 2013. 1–10. 87 indexed citations
16.
Szaflarski, Witold, Patrycja Sujka‐Kordowska, Radosław Januchowski, et al.. (2011). Expression of Cell Vault Components MVP, TEP1 and vPARP in Cancerous Ovarian Tissues. Advances in Clinical and Experimental Medicine. 20(3). 285–294. 2 indexed citations
17.
Januchowski, Radosław, Mariusz Wudarski, H Chwalińska-Sadowska, & Paweł P. Jagodzińśki. (2007). Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4+ T cells of patients with systemic lupus erythematosus. Clinical Rheumatology. 27(1). 21–27. 38 indexed citations
18.
19.
Januchowski, Radosław & Paweł P. Jagodzińśki. (2005). Effect of 5-Azacytidine and Procainamide on CD3-ζ Chain Expression in Jurkat T Cells. Biomedicine & Pharmacotherapy. 59(3). 122–126. 7 indexed citations
20.
Jagodzińśki, Paweł P., et al.. (2003). 15 th European Immunology Congress EFIS 2003. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 20(5). 322–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Curt Balch Breakdown of academic impact, for papers by Naoyo Nishida Breakdown of academic impact, for papers by Lijun Di Breakdown of academic impact, for papers by Danhui Weng Breakdown of academic impact, for papers by Noor A. Lokman Breakdown of academic impact, for papers by Vijay Pandey Breakdown of academic impact, for papers by Douglas C. Marchion Breakdown of academic impact, for papers by Imayavaramban Lakshmanan Breakdown of academic impact, for papers by Yubin Mao Breakdown of academic impact, for papers by Luca Pasquini
Rankless by CCL
2026